Cannabis investors face a red day with pot stocks taking hits on Thursday (September 27) after the Ontario provincial government outlined its decision to restrict LPs to one retail license in the province.

Ontario’s Attorney General Caroline Mulroney stated during a press conference there would be no limit on the total amount of licenses given out to Canadian LPs, but would instead be given the chance to apply for a “single retail operator license” only.

“Any licensed producer will be permitted to hold a single retail license at a single production site located in Ontario,” Mulroney said. The province will also limit how many licenses a specific company or person may hold.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

The new Ontario plan will see the installation of these shops by April of next year.

Canadian LP Canopy Growth (NYSE:CGC,TSX:WEED), issued a response on Thursday to the Ontario legislation.

The company hinted to shareholders it still plans to pursue “additional retail capabilities” through the Tokyo Smoke platform and potential investments from Canopy Rivers (TSXV:RIV).

When it comes to Ontario, the producer will seek its single retail license for its headquarters in Smith Falls.

Allan Rewak, executive director of The Cannabis Council of Canada, an association representing the interests of Canadian LPs, told the Investing News Network (INN) the council is “eagerly awaiting the introduction of legislation” in order to better understand how exactly the government is planning its approach.

The council had previously issued a warm response to the new Ontario retail framework implemented by Premier Doug Ford.

Frank Robinson, a partner in the franchise law group at Cassels Brock, said the new regulations will “shut out” the big producers and create opportunities for franchising by LPs.

“The only way [LPs] will be able to get their logos and brands on storefronts is to license or franchise all of these small business people to which the province wants to allow access,” Robinson said.

“This sets the stage for a varied and comprehensive cannabis retail experience, which should be expected to include the use of franchise systems, helping operators market faster, harness established operating systems, create quality and brand reliability and keep shelves stocked.”

Market reaction

The Horizons Marijuana Life Science Index ETF (TSX:HMMJ), which added nine new stocks into its holdings on Wednesday (September 26) and the Evolve Marijuana ETF (TSX:SEED) both declined in value on Thursday’s trading session.

As of 12:30 p.m. EST, HMMJ and SEED saw drops of 0.99 and 2.37 percent respectively. HMMJ holds a price of C$23.98 and SEED is valued at C$23.90.

Another indicator of the overall Canadian market is the Marijuana Index from The Arcview Group. On Tuesday (September 25), the index showed all but one of its 17 constituents with a loss. The overall index was down 31.19 percent in value.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement, Harvest shareholders will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held.

Halper Sadeh encourages Harvest Health shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or or .

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, announced today the appointment of Cameron Wickham as a Director, Chief Executive Officer and Corporate Secretary of the Company and Ankit Gosain as Chief Financial Officer of the Company, effective May 7, 2021.

Daniel Pelchovitz, the Company’s former Chief Executive Officer, will continue with Spyder as a Director of the Company and as Chief Executive Officer of Spyder Cannabis Subco Inc., the Company’s Alcohol and Gaming Commission of Ontario (AGCO)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Niagara Falls, Ontario and has submitted two additional Retail Store Authorizations to the AGCO, and The Green Spyder Inc., the Company’s Alberta Gaming, Liquor & Cannabis (AGLC)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Calgary, Alberta.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.

1Q 2021 Financial Highlights (Unaudited)

Keep reading... Show less

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (OTC: HRVSF) in connection with the proposed acquisition of the Company by Trulieve Cannabis Corp. (“Trulieve”) (OTC: TCNNF). Under the terms of the merger agreement, Harvest shareholders will receive 0.1170 shares of Trulieve common stock for each Harvest share that they own, representing implied per-share merger consideration of approximately $4.79 based upon Trulieve’s May 7, 2021 closing price of $40.92 . Upon consummation of the transaction, current Harvest shareholders will own only 26.7% of the issued and outstanding pro forma Trulieve shares.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Participants may access a live webcast of the presentation by going to the Upcoming Events page at . A replay will be made available shortly following the live presentation.

Keep reading... Show less